Skip to main content

Table 3 Secondary endpoints

From: Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial

Single digit and composite of death from vascular causes (death from cardiovascular causes or cerebrovascular causes and any death without another known cause), MI, stroke, TIA, severe recurrent ischemia, recurrent ischemia, or other arterial thrombotic event

Death from any cause

Any stent thrombosis according to the ARC criteria

Target vessel revascularization (TVR)

Target lesion revascularization (TLR)

NACE (net adverse cardiac events) occurred in the period between admission and coronary revascularization defined as a composite of death from vascular causes (death from cardiovascular causes or cerebrovascular causes and any death without another known cause), non-fatal MI, or non-fatal stroke, and BARC type 2, 3, 4, and 5 bleeding

Compliance to mandated antiplatelet therapy

BARC type 2, 3, 4, and 5 bleeding (single digit and composite)

All TIMI major, major life-threatening, and minor bleeding

All CABG surgery-related TIMI major, minor, and composite of TIMI major or minor bleeding

Non-CABG surgery-related TIMI major, minor, and composite of TIMI major or minor bleeding